FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Lillys Ebglyss Approved for Eczema

FDA approves an Eli Lilly BLA for Ebglyss (lebrikizumab-lbkz) for treating adults and children 12 years of age and older with moderate-to-severe atopi...

Medical Devices

FDA Clears SamanTrees Histolog Scanner

FDA clears a SamanTree Medical 510(k) for its Histolog Scanner for imaging the internal microstructure of tissues including identifying cells, vessels...

latest-news-card-1
Human Drugs

Genentechs Ocrevus Zunovo Approved for MS

FDA approves Genentechs Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) twice-a-year subcutaneous injection for treating relapsing multiple sclero...

latest-news-card-1
Human Drugs

Senators Introduce Bill to Reduce Animal Testing

A group of bipartisan U.S. senators introduce the FDA Modernization Act 3.0, a bill to direct the agency to finally implement the FDA Modernization Ac...

latest-news-card-1
Human Drugs

Feedback Sought on Integrated Review Document

FDA seeks comments on the use of its Integrated Review document as it decides to expand its use beyond new molecular entities, original BLAs, and sele...

latest-news-card-1
Human Drugs

FDA Publishes 8th Revision of Electronic Format Guide

FDA publishes the eighth revision of a guidance on providing regulatory submissions for certain drug products in electronic format.

latest-news-card-1
Medical Devices

Apple AirPods Hearing Software Authorized

FDA authorizes Apples Hearing Aid Feature software to use with compatible AirPods Pro headphones to operate as an over-the-counter hearing aid for mil...

latest-news-card-1
Biologics

Tremfya Secures Approval for Ulcerative Colitis

FDA approves Johnson & Johnsons Tremfya (guselkumab) for treating adults with moderately to severely active ulcerative colitis.

latest-news-card-1
Biologics

Gilead Positive on Twice-Yearly HIV Drug Data

Gilead Sciences says data from a second pivotal Phase 3 clinical trial investigating its twice-yearly injectable lenacapavir show that it reduced HIV ...

latest-news-card-1
Biologics

GSK Moves mRNA Flu Vaccine to Phase 3

GSK moves its mRNA seasonal influenza vaccine program into Phase 3 after reporting favorable Phase 2 data.